Cytokines profile and peripheral blood mononuclear cells morphology in Rett and autistic patients

Cytokine

Volumn 77, Issue , 2016, Pages 180-188

  Pecorelli, Alessandra ^a   Cervellati, Franco ^b   Belmonte, Giuseppe ^b   Montagner, Giulia ^b   Waldon, PhiAnh ^d   Hayek, Joussef ^a   Gambari, Roberto ^b   Valacchi, Giuseppe ^b,c  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c Kyung Hee University   (South Korea)

^d HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Autism spectrum disorders; Chemokine; Cytokine; Immune system; Mitochondria; Peripheral blood mononuclear cells; Rett syndrome

Indexed keywords

CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 8; INTERLEUKIN 9; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; ARTICLE; AUTISM; CELL ISOLATION; CELL STRUCTURE; CELL ULTRASTRUCTURE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; REAL TIME POLYMERASE CHAIN REACTION; RETT SYNDROME; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; ADOLESCENT; BLOOD; ENZYME IMMUNOASSAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MONONUCLEAR CELL; PRESCHOOL CHILD; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASTRUCTURE; YOUNG ADULT;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-13; INTERLEUKIN-15; INTERLEUKIN-1BETA; INTERLEUKIN-8; INTERLEUKIN-9; LEUKOCYTES, MONONUCLEAR; MICROSCOPY, ELECTRON, TRANSMISSION; RETT SYNDROME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84948767647     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.10.002     Document Type: Article

References (48)

1. Borsini A., Zunszain P.A., Thuret S., Pariante C.M. The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci. 2015, 38:145-157.
2. Goines P.E., Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol. Teratol. 2013, 36:67-81.
3. Mead J., Ashwood P. Evidence supporting an altered immune response in ASD. Immunol. Lett. 2015, 163:49-55.
4. Guy J., Cheval H., Selfridge J., Bird A. The role of MeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 2011, 27:631-652.
5. J. Christodoulou, G. Ho, MECP2-related disorders, 2001 Oct 3 (Updated 2012 Jun 28), in: R.A. Pagon, M.P. Adam, H.H. Ardinger, et al. (Eds.), GeneReviews® [Internet], University of Washington, Seattle, Seattle (WA), 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1497/.
6. Hagberg B. Clinical manifestations and stages of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 2002, 8:61-65.
7. Percy A.K. Rett syndrome: exploring the autism link. Arch. Neurol. 2011, 68:985-989.
8. Derecki N.C., Privman E., Kipnis J. Rett syndrome and other autism spectrum disorders-brain diseases of immune malfunction?. Mol. Psychiatr. 2010, 15:355-363.
9. Theoharides T.C., Athanassiou M., Panagiotidou S., Doyle R. Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders. J. Neuroimmunol. 2015, 279C:33-38.
10. Ramesh G., MacLean A.G., Philipp M.T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013, 2013:480739.
11. Neul J.L., Kaufmann W.E., Glaze D.G., Christodoulou J., Clarke A.J., Bahi-Buisson N., Leonard H., Bailey M.E., Schanen N.C., Zappella M., Renieri A., Huppke P., Percy A.K., RettSearch Consortium Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol. 2010, 68:944-950.
12. Cervellati F., Muresan X.M., Sticozzi C., Gambari R., Montagner G., Forman H.J., Torricelli C., Maioli E., Valacchi G. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol. In Vitro 2014, 28:999-1005.
13. Pecorelli A., Leoni G., Cervellati F., Canali R., Signorini C., Leoncini S., Cortelazzo A., De Felice C., Ciccoli L., Hayek J., Valacchi G. Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patients. Mediators Inflamm. 2013, 2013:137629.
14. Balmer D., Arredondo J., Samaco R.C., LaSalle J.M. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum. Genet. 2002, 110:545-552.
15. Fiumara A., Sciotto A., Barone R., D'Asero G., Munda S., Parano E., Pavone L. Peripheral lymphocyte subsets and other immune aspects in Rett syndrome. Pediatr. Neurol. 1999, 21:619-621.
16. Maezawa I., Swanberg S., Harvey D., LaSalle J.M., Jin L.W. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J. Neurosci. 2009, 29:5051-5061.
17. Lioy D.T., Garg S.K., Monaghan C.E., Raber J., Foust K.D., Kaspar B.K., Hirrlinger P.G., Kirchhoff F., Bissonnette J.M., Ballas N., Mandel G. A role for glia in the progression of Rett's syndrome. Nature 2011, 475(7357):497-500.
18. Derecki N.C., Cronk J.C., Lu Z., Xu E., Abbott S.B., Guyenet P.G., Kipnis J. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 2012, 484:105-109.
19. G. Hayek, E. Bianchi, C. Milano, G. Cardinali, M. Guarna, Antineuronal autoantibodies in Rett syndrome patients, in: Hand in Hand with Rett Syndrome, Proceedings of the World Congress on Rett Syndrome, Gothenburg, Sweden, August 30-September 1, 1996, Eur. Child Adolesc. Psychiatr., vol. 6, 1997, p. 85.
20. Papini A.M., Nuti F., Real-Fernandez F., Rossi G., Tiberi C., Sabatino G., Pandey S., Leoncini S., Signorini C., Pecorelli A., Guerranti R., Lavielle S., Ciccoli L., Rovero P., De Felice C., Hayek J. Immune dysfunction in Rett syndrome patients revealed by high levels of serum anti-N(Glc) IgM antibody fraction. J. Immunol. Res. 2014, 2014:260973.
21. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 2003, 8:223-246.
22. Li C., Jiang S., Liu S.Q., Lykken E., Zhao L.T., Sevilla J., Zhu B., Li Q.J. MeCP2 enforces Foxp3 expression to promote regulatory T cells' resilience to inflammation. Proc. Natl. Acad. Sci. USA 2014, 111(27):E2807-E2816.
23. De Felice C., Ciccoli L., Leoncini S., Signorini C., Rossi M., Vannuccini L., Guazzi G., Latini G., Comporti M., Valacchi G., Hayek J. Systemic oxidative stress in classic Rett syndrome. Free Radic. Biol. Med. 2009, 47:440-448.
24. Pan H.F., Leng R.X., Li X.P., Zheng S.G., Ye D.Q. Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases. Cytokine Growth Factor Rev. 2013, 24(6):515-522.
25. Cappuzzello C., Di Vito L., Melchionna R., Melillo G., Silvestri L., Cesareo E., Crea F., Liuzzo G., Facchiano A., Capogrossi M.C., Napolitano M. Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure. J. Transl. Med. 2011, 9:28.
26. Acampa M., Guideri F. Cardiac disease and Rett syndrome. Arch. Dis. Child. 2006, 91(5):440-443.
27. De Felice C., Maffei S., Signorini C., Leoncini S., Lunghetti S., Valacchi G., D'Esposito M., Filosa S., Della Ragione F., Butera G., Favilli R., Ciccoli L., Hayek J. Subclinical myocardial dysfunction in Rett syndrome. Eur. Heart J. Cardiovasc. Imag. 2012, 13(4):339-345.
28. Ramirez J.M., Ward C.S., Neul J.L. Breathing challenges in Rett syndrome: lessons learned from humans and animal models. Respir. Physiol. Neurobiol. 2013, 189:280-287.
29. Hagebeuk E.E., Bijlmer R.P., Koelman J.H., Poll-The B.T. Respiratory disturbances in Rett syndrome: don't forget to evaluate upper airway obstruction. J. Child Neurol. 2012, 27:888-892.
30. De Felice C., Della Ragione F., Signorini C., Leoncini S., Pecorelli A., Ciccoli L., Scalabrì F., Marracino F., Madonna M., Belmonte G., Ricceri L., De Filippis B., Laviola G., Valacchi G., Durand T., Galano J.M., Oger C., Guy A., Bultel-Poncé V., Guy J., Filosa S., Hayek J., D'Esposito M. Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome. Neurobiol. Dis. 2014, 68:66-77.
31. McNicholas W.T. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am. J. Respir. Crit. Care Med. 2009, 180:692-700.
32. Turner M.D., Nedjai B., Hurst T., Pennington D.J. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim. Biophys. Acta 2014, 1843(11):2563-2582.
33. Bianciardi G., Acampa M., Lamberti I., Sartini S., Servi M., Biagi F., Bocchi V., Hayek J., Pastorelli M. Microvascular abnormalities in Rett syndrome. Clin. Hemorheol. Microcirc. 2013, 54(1):109-113.
34. Goswami R., Kaplan M.H. A brief history of IL-9. J. Immunol. 2011, 186:3283-3288.
35. Corren J. Role of interleukin-13 in asthma. Curr. Allergy Asthma Rep. 2013, 13:415-420.
36. De Felice C., Guazzi G., Rossi M., Ciccoli L., Signorini C., Leoncini S., Tonni G., Latini G., Valacchi G., Hayek J. Unrecognized lung disease in classic Rett syndrome: a physiologic and high-resolution CT imaging study. Chest 2010, 138:386-392.
37. Saidijam M., Tootoonchi A.S., Goodarzi M.T., Hassanzadeh T., Borzuei S.H., Yadegarazari R., Shabab N. Expression of interleukins 7 & 8 in peripheral blood mononuclear cells from patients with metabolic syndrome: a preliminary study. Indian J. Med. Res. 2014, 140(2):238-243.
38. O'Rourke R.W., Kay T., Lyle E.A., Traxler S.A., Deveney C.W., Jobe B.A., Roberts C.T., Marks D., Rosenbaum J.T. Alterations in peripheral blood lymphocyte cytokine expression in obesity. Clin. Exp. Immunol. 2006, 146(1):39-46.
39. Codorean E., Nichita C., Albulescu L., Răducan E., Popescu I.D., Lonită A.C., Albulescu R. Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro. Roum. Arch. Microbiol. Immunol. 2010, 69:13-19.
40. Rossignol D.A., Frye R.E. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatr. 2012, 17(3):290-314.
41. Rossignol D.A., Frye R.E. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front. Physiol. 2014, 5:150.
42. Napoli E., Wong S., Hertz-Picciotto I., Giulivi C. Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics 2014, 133(5):e1405-e1410.
43. Rose S., Frye R.E., Slattery J., Wynne R., Tippett M., Pavliv O., Melnyk S., James S.J. Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort. PLoS ONE 2014, 9(1):e85436.
44. Hackenbrock C.R. Ultrastructural bases for metabolically linked mechanical activity in mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in isolated liver mitochondria. J. Cell Biol. 1966, 30(2):269-297.
45. De Filippis B., Valenti D., de Bari L., De Rasmo D., Musto M., Fabbri A., Ricceri L., Fiorentini C., Laviola G., Anna Vacca R. Mitochondrial free radicals overproduction due to respiratory chain impairment in brain of a mouse model of Rett syndrome. Protective effect of CNF1. Free Radic. Biol. Med. 2015, 83:167-177.
46. Valenti D., de Bari L., De Filippis B., Henrion-Caude A., Vacca R.A. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome. Neurosci. Biobehav. Rev. 2014, 46(Pt 2):202-217.
47. Belichenko P.V., Wright E.E., Belichenko N.P., Masliah E., Li H.H., Mobley W.C., Francke U. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J. Comp. Neurol. 2009, 514:240-258.
48. Arismendi-Morillo G. Electron microscopy morphology of the mitochondrial network in human cancer. Int. J. Biochem. Cell Biol. 2009, 41:2062-2068.